Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 28th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

For the three months ended September 30th, 2018 vs September 30th, 2017, Gartner reported revenue of $921.67MM vs $828.09MM (up 11.30%) and analysts estimated basic earnings per share $0.13 vs -$0.53. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Gartner reported revenue of $3,311.49MM vs $2,444.54MM (up 35.46%) and analysts estimated basic earnings per share $0.04 vs $2.34 (down 98.29%). Analysts expect earnings to be released on February 5th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $1.17. The estimated EPS forecast for the next fiscal year is $4.25 and is expected to report on February 5th, 2019.

For the three months ended September 30th, 2018 vs September 30th, 2017, CONVERGEONE HLD reported revenue of $404.75MM vs $245.41MM (up 64.93%) and analysts estimated basic earnings per share -$0.64 vs $0.03. Analysts expect earnings to be released on March 19th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.19. The estimated EPS forecast for the next fiscal year is $1.08 and is expected to report on March 19th, 2019.

For the twelve months ended December 31st, 2017 vs December 31st, 2016, Syros Pharmaceuticals reported revenue of $1.10MM vs $0.32MM (up 247.32%) and analysts estimated basic earnings per share -$2.13 vs -$4.05. Analysts expect earnings to be released on March 11th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.58. The estimated EPS forecast for the next fiscal year is -$1.93 and is expected to report on March 11th, 2019.

For the three months ended September 30th, 2018 vs September 30th, 2017, Akers Biosciences reported revenue of $0.56MM vs $0.68MM (down 17.56%) and basic earnings per share -$0.26 vs -$1.04. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Akers Biosciences reported revenue of $3.35MM vs $2.96MM (up 13.30%) and analysts estimated basic earnings per share -$6.24 vs -$4.88. Analysts expect earnings to be released on April 2nd, 2019. The report will be for the fiscal period ending December 31st, 2018.

For the three months ended July 31st, 2018 vs July 31st, 2017, Cracker Barrel Old Country Store reported revenue of $810.89MM vs $743.23MM (up 9.10%) and analysts estimated basic earnings per share $2.55 vs $2.25 (up 13.33%). For the twelve months ended July 31st, 2018 vs July 31st, 2017, Cracker Barrel Old Country Store reported revenue of $3,030.45MM vs $2,926.29MM (up 3.56%) and analysts estimated basic earnings per share $10.31 vs $8.40 (up 22.74%). Analysts expect earnings to be released on February 19th, 2019. The report will be for the fiscal period ending January 31st, 2019. The reported EPS for the same quarter last year was $2.73. The estimated EPS forecast for the next fiscal year is $9.25 and is expected to report on September 17th, 2019.

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at [email protected].

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.